{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T07:27:43Z","timestamp":1751873263789,"version":"3.37.3"},"reference-count":19,"publisher":"Endocrinology Research Centre","issue":"5","license":[{"start":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T00:00:00Z","timestamp":1608854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.probl-endojournals.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":["www.probl-endojournals.ru"],"crossmark-restriction":true},"short-container-title":["Probl Endokrinol (Mosk)"],"abstract":"<jats:p>The main autoimmune thyroid diseases are Hashimoto's thyroiditis (HT) and Graves' disease (GD). Despite the significant differences in a pathogenesis and a clinical picture between HT and GD, the literature describes the cases of the conversion of one autoimmune disease to another, which, according to one version, is associated with a change in the balance between the levels of a stimulating and blocking antibodies to the thyroid-stimulating hormone receptor. At the same time, there are more frequent observations of the transition of GD to HT, and much less often describe, on the contrary, the development of GD against the background of HT. The article presents a clinical case of the conversion of HT to GD. A detailed algorithm of the conservative management according to the \u00abblock-replace\u00bb scheme is described, indicating the results of laboratory and instrumental examination. At the time of describing the clinical case, the result of the treatment can be considered successful. The predictors such as a low level of the thyroid-stimulating hormone receptor and thyroid volume before discontinuation of the thyrostatic therapy suggest a low risk of the recrudescence of GD.According to the authors, the phenomenon of the conversion of one autoimmune thyroid disease to another, in addition to the scientific interest, is important for the practitioners, since a timely change in the diagnostic paradigm can significantly change the treatment strategy and the favorably affect the prognosis of disease, preventing the development of complications.<\/jats:p>","DOI":"10.14341\/probl12420","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T10:57:25Z","timestamp":1609153045000},"page":"24-30","update-policy":"https:\/\/doi.org\/10.14341\/crossmarkpolicy2018","source":"Crossref","is-referenced-by-count":2,"title":["The development of Graves' disease after long-term hypothyroidism due to Hashimoto's disease"],"prefix":"10.14341","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2770-1205","authenticated-orcid":true,"given":"E. A.","family":"Panfilova","sequence":"first","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1434-9671","authenticated-orcid":true,"given":"L. P.","family":"Kruk","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9963-6783","authenticated-orcid":true,"given":"M. P.","family":"Isaeva","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0473-8144","authenticated-orcid":true,"given":"P. O.","family":"Osmanova","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5824-9536","authenticated-orcid":true,"given":"F. A.","family":"Bostanova","sequence":"additional","affiliation":[{"name":"Russian Medical Academy of Continuous Professional Education"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8520-8702","authenticated-orcid":true,"given":"E. A.","family":"Troshina","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5458","published-online":{"date-parts":[[2020,12,25]]},"reference":[{"key":"ref1","unstructured":"Dong YH, Fu DG. Autoimmune thyroid disease: Mechanism, genetics and current knowledge. Eur Rev Med Pharmacol Sci. 2014;18:3611-3618."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Frohlich E, Wahl R. Thyroid autoimmunity: Role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Front Immunol. 2017;8:521. doi: https:\/\/doi.org\/10.3389\/fimmu.2017.00521","DOI":"10.3389\/fimmu.2017.00521"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Kung AWC, Lau KS, Kohn LD. Epitope Mapping of TSH ReceptorBlocking Antibodies in Graves' Disease That Appear during Pregnancy. The Journal of Clinical Endocrinology & Metabolism. 2001;86(8)3647-3653.","DOI":"10.1210\/jc.86.8.3647"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Gonzalez-Aguilera B, Betea D, Lutteri L, et al. Conversion to Graves disease from Hashimoto thyroiditis: a study of 24 patients. Arch Endocrinol Metab. 2018;62(6):609-614. doi: https:\/\/doi.org\/10.20945\/2359-3997000000086","DOI":"10.20945\/2359-3997000000086"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Aversa T, Valenzise M, Salerno M, et al. Metamorphic thyroid autoimmunity in Down Syndrome: From Hashimoto's thyroiditis to Graves' disease and beyond. Ital J Pediatr. 2015;41:87. doi: https:\/\/doi.org\/10.1186\/s13052-015-0197-4","DOI":"10.1186\/s13052-015-0197-4"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Furqan S, Haque NU, Islam N. Conversion of autoimmune hypothyroidism to hyperthyroidism. BMC Res Notes. 2014;7:489. doi: https:\/\/doi.org\/10.1186\/1756-0500-7-489","DOI":"10.1186\/1756-0500-7-489"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Joplin GF, Fraser R. Thyrotoxicosis Developing in Recurrent Nodular Goitre with Focal Thyroiditis. J R Soc Med. 1959;52:177-178.","DOI":"10.1177\/003591575905200310"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Doniach D, Hudson RV, Roitt LM. Human autoimmune thyroiditis; Clinical studies. Brit Med J. 1960;1(5170):365-373.","DOI":"10.1136\/bmj.1.5170.365"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Gavras L, Thomson JA. Late thyrotoxicosis complicating autoimmune thyroiditts. Acta Endocrinol. 1972;69:44-46.","DOI":"10.1530\/acta.0.0690041"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Takasu N, Yamada T, Sato A, et al. Graves' Disease Following Hypothyroidism Due To Hashimoto's Disease: Studies Of Eight Cases. Clin Endocrinol (Oxf). 1990;33(6):687-698. doi: https:\/\/doi.org\/10.1111\/j.1365-2265.1990.tb03906.x","DOI":"10.1111\/j.1365-2265.1990.tb03906.x"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Ahmad E, Hafeez K, Arshad MF, Isuga J, Vrettos A. Hypothyroidism conversion to hyperthyroidism: it's never too late. Endocrinol Diabetes Metab Case Reports. 2018;2018(6):687-698. doi: https:\/\/doi.org\/10.1530\/EDM-18-0047","DOI":"10.1530\/EDM-18-0047"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Moriarty M, Mills E, Yap HL, Hamda A. Conversion of autoimmune hypothyroidism to hyperthyroidism with thyroid eye disease. Tache Y, ed. Endocr Abstr. 2015;12(7):e0180745. doi: https:\/\/doi.org\/10.1530\/endoabs.37.EP1307","DOI":"10.1530\/endoabs.37.EP1307"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Takasu N, Matsushita M. Changes of TSH-Stimulation Blocking Antibody (TSBAb) and Thyroid Stimulating Antibody (TSAb) Over 10 Years in 34 TSBAb-Positive Patients with Hypothyroidism and in 98 TSAb-Positive Graves' Patients with Hyperthyroidism: Reevaluation of TSBAb and TSAb in TSH-Receptor-Antibody (TRAb)-Positive Patients. J Thyroid Res. 2012;2012:182176.","DOI":"10.1155\/2012\/182176"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Troshina EA, Panfilova EA, Panevin TS. Autoimmune polyglandular disorders in myotonic dystrophy. Problems of endocrinology. 2019;165(3):155-160. (In Russ.). doi: 10.14341\/probl9775","DOI":"10.14341\/probl9775"},{"key":"ref15","unstructured":"\u041f\u0440\u043e\u0435\u043a\u0442 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0439 \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u043e\u0439 \u0430\u0441\u0441\u043e\u0446\u0438\u0430\u0446\u0438\u0438 \u044d\u043d\u0434\u043e\u043a\u0440\u0438\u043d\u043e\u043b\u043e\u0433\u043e\u0432 \u00ab\u0413\u0438\u043f\u043e\u0442\u0438\u0440\u0435\u043e\u0437\u00bb. \u2014 \u041c., 2019 \/ \u041f\u043e\u0434 \u0440\u0435\u0434. \u0430\u043a\u0430\u0434. \u0414\u0435\u0434\u043e\u0432\u0430 \u0418.\u0418., \u0430\u043a\u0430\u0434. \u041c\u0435\u043b\u044c\u043d\u0438\u0447\u0435\u043d\u043a\u043e \u0413.\u0410. \u0414\u043e\u0441\u0442\u0443\u043f\u043d\u043e \u043f\u043e: https:\/\/www.endocrincentr.ru\/sites\/default\/files\/specialists\/science\/clinic-recomendations\/gipotireoz.proekt.klin_.rek_3.pdf, \u0434\u0430\u0442\u0430 \u043e\u0431\u0440\u0430\u0449\u0435\u043d\u0438\u044f 21.09.2020."},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Ekpebegh C, Elmezughi K, Mtingi L. Graves' disease following hypothyroidism due to Hashimoto's thyroiditis in a black South African lady: A case report. Pan Afr Med J. 2019. doi: https:\/\/doi.org\/10.11604\/pamj.2019.32.186.18713","DOI":"10.11604\/pamj.2019.32.186.18713"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Shong YK, Cho BY, Hong SK, Lee HK, Koh CS, Min HK. Pathogenetic role of thyrotropin receptor antibody in the development of hyperthyroidism following primary hypothyroidism. Korean J Intern Med. 1989. doi: https:\/\/doi.org\/10.3904\/kjim.1989.4.2.118","DOI":"10.3904\/kjim.1989.4.2.118"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Wong M, Inder WJ. Alternating hyperthyroidism and hypothyroidism in Graves' disease. Clin Case Rep. 2018;6(9):1684-1688. doi: 10.1002\/ccr3.1700","DOI":"10.1002\/ccr3.1700"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Morshed SA, Latif R, Davies TF. Delineating the autoimmune mechanisms in Graves' disease. Immunol Res. 2012;54(1-3):191-203. doi: 10.1007\/s12026-012-8312-8","DOI":"10.1007\/s12026-012-8312-8"}],"container-title":["Problems of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/viewFile\/12420\/9830","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T10:57:32Z","timestamp":1609153052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/view\/12420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,25]]},"references-count":19,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,12,25]]}},"URL":"https:\/\/doi.org\/10.14341\/probl12420","relation":{},"ISSN":["2308-1430","0375-9660"],"issn-type":[{"type":"electronic","value":"2308-1430"},{"type":"print","value":"0375-9660"}],"subject":[],"published":{"date-parts":[[2020,12,25]]}}}